The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Tirzepatide Reviews in the UK — What NHS Patients Report
Tirzepatide (brand name Mounjaro) is a prescription-only weekly weight loss injection now available through NHS specialist services in the UK. Real patient reviews and clinical data show mixed experiences — some people report significant weight loss alongside reduced appetite, whilst others experience side effects like nausea or notice modest results. This guide explains what actual UK patients report, NHS eligibility criteria, and how tirzepatide compares to other available options. All experiences vary based on individual health, dose, and lifestyle factors.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
What Real NHS Patients Report About Tirzepatide
Patient reviews of tirzepatide (this GLP-1 receptor agonist medication) from UK NHS services highlight several consistent themes:
- Appetite reduction: Most UK patients report noticeably reduced hunger and food cravings, particularly within the first 4–8 weeks. Many describe eating significantly smaller portions without feeling deprived.
- Weight loss results: Clinical trials showed average weight loss of 15–21% of body weight over 72 weeks. Real NHS patients report losing between 5–25kg, though individual results vary considerably. Our free GLP-1 weight loss calculator can help estimate potential outcomes at different doses.
- Side effects: Nausea is the most commonly reported side effect in the first weeks, often improving as the body adjusts. Constipation, diarrhoea, and reduced energy are also frequently mentioned in patient reviews.
- Lifestyle impact: Many UK patients note that tirzepatide works best when combined with dietary changes and physical activity — it is not a standalone solution.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
NHS Eligibility and How to Access Tirzepatide in the UK
Access to tirzepatide through the NHS requires referral to a tier 3 specialist weight management service. Your GP can refer you if you meet NICE-approved criteria: BMI of 30 or above (or 27 or above with weight-related health conditions such as type 2 diabetes, high blood pressure, or sleep apnoea). For adults of South Asian, Chinese, Black African, or Black Caribbean heritage, lower BMI thresholds apply (27.5 and above). Waiting times vary significantly by region — some NHS areas have waiting lists of several months or longer. Private tirzepatide prescriptions are also available through online assessment, often with faster access. Check your local integrated care board (ICB) website for NHS tier 3 service availability in your area.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
What do UK patients say about tirzepatide side effects?
Common side effects reported in UK patient reviews include nausea (especially in the first weeks), constipation, diarrhoea, and reduced appetite. Most patients find side effects improve within 2–4 weeks as their body adjusts. Serious side effects are rare but require immediate GP attention. Always report any concerns to your prescriber.
Is tirzepatide available on the NHS in the UK?
Yes, tirzepatide (Mounjaro) is now NICE-approved for NHS use through tier 3 specialist weight management services. You need a GP referral and must meet eligibility criteria (BMI 30+ or 27+ with health conditions). Availability and waiting times vary by region. Private prescriptions are also available without NHS referral.
How much weight do UK patients lose on tirzepatide?
Clinical trials showed average weight loss of 15–21% of body weight. Real UK patient reviews report losing 5–25kg depending on starting weight, dose, and lifestyle changes. Individual results vary significantly. Use our free GLP-1 weight loss calculator to estimate potential outcomes based on your individual circumstances.
How does tirzepatide compare to other weight loss injections in the UK?
Tirzepatide is a dual GIP and GLP-1 receptor agonist, making it different from semaglutide (Wegovy), which activates only the GLP-1 pathway. Clinical evidence suggests tirzepatide may produce slightly greater average weight loss, but individual responses vary. Your prescriber can advise which is most suitable for you.
How long does tirzepatide take to work according to UK patient reviews?
Most UK patients report noticing appetite reduction within 1–2 weeks of starting. Measurable weight loss typically becomes apparent after 2–4 weeks. Full effects develop over several months as doses are increased. Patience and consistent lifestyle changes improve results — tirzepatide works best alongside a reduced-calorie diet and increased physical activity.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.